RANI THERAPEUTICS HOLDINGS

Rani Therapeutics (RANI) drops 7.35% to $0.58 on Oct 22, 2026, falling below its 200‑day SMA and 52‑week low—an in‑depth look at the stock’s performance and outlook.

Rani Therapeutics stock rises modestly at $0.65, trading below its 200‑day average; learn the latest price, volume, and market cap insights for this biotech contender.